NeuroSense Therapeutics Ltd. Gains 299.36%
Mon, Mar 21, 2022 at 05:30 PM
NeuroSense Therapeutics Ltd. (NRSN:NASDAQ) jumped higher at $6.23, a gain of 299.4%. On Fri, Mar 18, 2022, NRSN:NASDAQ hit a New 2-Week High of $1.56. The stock appeared on our News Catalysts scanner on Mon, Mar 21, 2022 at 04:58 PM in the 'BIOTECH' category. From Mon, Mar 07, 2022, the stock recorded 55.56% Up Days and 50.00% Green Days
The stock spiked on Tue, Mar 01, 2022 at $2.86 with a volume of 5M+.
About NeuroSense Therapeutics Ltd. (NRSN:NASDAQ)
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these...
Top 10 Gainers:
- NeuroSense Therapeutics Ltd. (NRSN:NASDAQ), 299.36%
- Clarus Therapeutics Holdings Inc. (CRXT:NASDAQ), 58.44%
- Yumanity Therapeutics Inc. (YMTX:NASDAQ), 58.04%
- BitNile Holdings Inc. (NILE:NYSEMKT), 48.56%
- UTime Limited (UTME:NASDAQ), 44.79%
- Dermata Therapeutics Inc. (DRMA:NASDAQ), 44%
- CYREN Ltd. (CYRN:NASDAQ), 43.22%
- PainReform Ltd. (PRFX:NASDAQ), 39.64%
- Corbus Pharmaceuticals Holdings, Inc. (CRBP:NASDAQ), 38.02%
- O2Micro International Limited (OIIM:NASDAQ), 34.37%